Trial Profile
TapERA: Maintaining remission in RA while tapering Etanercept
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2023
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TapERA
- 01 Jan 2023 Results assessing Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial published in the Clinical Rheumatology
- 05 Jun 2021 Results (n=66) of post-hoc analysis assessing patient perceived aspects of Ra flare by the Flare-Ra Questionnaire, presented at the 22nd Annual Congress of the European League Against Rheumatism
- 06 Jun 2020 Results from patients included in TapERA trial were used to assess if the Flare-Ra Questionnaire can identify omeract flares in Patients with Rheumatoid Arthritis, presented at the 21st Annual Congress of the European League Against Rheumatism